Important data after drug approval: comment ... [Arch Intern Med. 2012] - PubMed

loading

Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events". [Arch Intern Med. 2012]
Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events".
Jacobs JM, Stessman J. Arch Intern Med. 2012 Mar 12; 172(5):403-4. Epub 2012 Jan 9.
Anticoagulation therapy. Dabigatran and risk of myocardial infarction. [Nat Rev Cardiol. 2012]
Anticoagulation therapy. Dabigatran and risk of myocardial infarction.
Eikelboom JW, Weitz JI. Nat Rev Cardiol. 2012 Mar 13; 9(5):260-2. Epub 2012 Mar 13.
Dabigatran and myocardial infarction: meta-illusion? [Arch Intern Med. 2012]
Dabigatran and myocardial infarction: meta-illusion?
Correia LC, Lopes AA. Arch Intern Med. 2012 May 28; 172(10):823; author reply 823.
Review Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. [Arch Intern Med. 2012]
Review Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.
Uchino K, Hernandez AV. Arch Intern Med. 2012 Mar 12; 172(5):397-402. Epub 2012 Jan 9.
Review Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients. [Prescrire Int. 2012]
Review Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
[No authors listed]Prescrire Int. 2012 Feb; 21(124):33-6.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Important data after drug approval: comment on "Dabigatran association with high...
Important data after drug approval: comment on "Dabigatran association with higher risk of acute coronary events".
Arch Intern Med. 2012 Mar 12 ;172(5):404. doi: 10.1001/archinternmed.2011.2169. Epub 2012 Jan 9 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed